The antiestrogen ICI 182,780 abolishes developmental injury for murine embryos exposed in vitro to o,p'-DDT

Reproductive Toxicology

Volumn 14, Issue 3, 2000, Pages 225-234

  Greenlee, Anne R ^a   Quail, Cory A ^a   Berg, Richard L ^b  

^a 1000 North Oak Avenue ^*  (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

Anti estrogen; Apoptosis; Cell number; Development; Embryo; ICI 182,780; Pesticide; Toxicity

Indexed keywords

1,1,1 TRICHLORO 2 (2 CHLOROPHENYL) 2 (4 CHLOROPHENYL)ETHANE; 7ALPHA [9 (4,4,5,5,5 PENTAFLUOROPENTYLSULFINYL)NONYL]ESTRA 1,3,5(10) TRIENE 3,17BETA DIOL; ANTIESTROGEN; CHLORPHENOTANE; DRUG DERIVATIVE; ESTRADIOL; ESTROGEN; O,P'-DDT;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; BLASTOCYST; CELL COUNT; CELL DEATH; CYTOLOGY; DEVELOPMENTAL DISORDER; DRUG EFFECT; DRUG INTERACTION; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE; FETUS DEVELOPMENT; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PREGNANCY; PREIMPLANTATION EMBRYO; PRONUCLEUS;

ANIMALS; APOPTOSIS; BLASTOCYST; CELL COUNT; DDT; DRUG INTERACTIONS; EMBRYONIC AND FETAL DEVELOPMENT; EMBRYONIC DEVELOPMENT; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS, NON-STEROIDAL; FEMALE; MALE; MICE; MODELS, BIOLOGICAL; PREGNANCY;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0034101175     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-6238(00)00072-1     Document Type: Article

References (33)

1. Shelby M.D., Newbold R.R., Tully D.B., Chae K., Davis V.L. Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect. 104:1996;1296-1300.
2. Soto AM, Lin T-M, Justicia H, Silvia RM, Sonnenschein C. An. "in culture" bioassay to assess the estrogenicity of xenobiotics (E-SCREEN). In: Colborn T, Clement C, editors. Chemically induced alterations in sexual and functional development: the wildlife/human connection. Princeton: Princeton Scientific Publishing Co Inc., 1992. p. 295-309.
3. Klotz D.M., Beckman B.S., Hill S.M., McLachlan J.A., Walters M.R., Arnold S.F. Identification of environmental chemicals with estrogenic activity using a combination of in vitro assays. Environ Health Perspect. 104:1996;1084-1089.
4. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-SCREEN assay as a tool to identify estrogens an update on estrogenic environmental pollutants . Environ Health Perspect. 103:(suppl. 7):1995;113-122.
5. Wakeling A.E. Use of pure antioestrogens to elucidate the mode of action of oestrogens. Biochem Pharmacol. 49:1995;1545-1549.
6. Spielmann H., Vogel R. Unique role of studies on preimplantation embryos to understand mechanisms of embryotoxicity in early pregnancy. Crit Rev Toxicol. 20:1989;51-64.
7. Greenlee AR, Quail CA, Berg RL. Developmental alterations in murine embryos exposed in vitro to an estrogenic pesticide, o,p′-DDT. Reprod Toxicol 1999;13, In press.
8. Hogan B, Costantini F, Lacy E, eds. Embryo transfers. In: Manipulating the mouse embryo: a laboratory manual. New York: Cold Spring Harbor Laboratory. 1986:135-45.
9. Hou Q., Gorski J. Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc Natl Acad Sci. 90:1993;9460-9464.
10. Hou Q., Paria B.C., Mui C., Dey S.K., Gorski J. Immunolocalization of estrogen receptor protein in the mouse blastocyst during normal and delayed implantation. Proc Natl Acad Sci. 93:1996;2376-2381.
11. Gorski J., Hou Q. Embryonic estrogen receptors do they have a physiological function? Environ Health Perspect. 103:(suppl. 7):1995;69-72.
12. Chen C.W., Hurd C., Vorojeikina D.P., Arnold S.F., Notides A.C. Transcriptional activation of the human estrogen receptor by DDT isomers and metabolites in yeast and MCF-7 cells. Biochem Pharmacol. 53:1997;1161-1172.
13. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, D. C.: National Academy Press, 1996.
14. Scott L., Whittingham D.G. Influence of genetic background and media components on the development of mouse embryos in vitro. Mol Reprod Dev. 43:1996;336-346.
15. Brison D.R., Schultz R.M. RT-PCR-based method to localize the spatial expression of genes in the mouse blastocyst. Mol Reprod Dev. 44:1996;171-178.
16. Brison D.R., Schultz R.M. Apoptosis during mouse blastocyst formation evidence for a role for survival factors including transforming growth factor α Biol Reprod. 56:1977;1088-1096.
17. R Software. Changes and Enhancements Through Release 6.12. Cary, NC: SAS Institute Inc, 1997.
18. Hogan B, Costantini F, Lacy E, eds. Summary of mouse development. In: Manipulating the mouse embryo: a laboratory manual. New York: Cold Spring Harbor Laboratory. 1986. p. 33.
19. Korach K.S., Chae K., Gibson M., Curtis S. Estrogen receptor stereochemistry ligand binding and hormonal responsiveness . Steroids. 56:1991;263-270.
20. Pilat M.J., Hafner M.S., Kral L.G., Brooks S.C. Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens. Biochemistry. 32:1993;7009-7015.
21. Sen Gupta J., Dey S.K., Dickmann Z. Evidence that "embryonic estrogen" is a factor that controls the development of the mouse preimplantation embryo. Steroids. 29:1977;363-369.
22. Sengupta J., Roy S.K., Manchanda S.K. Effect of an oestrogen synthesis inhibitor, 1,4,6-androstatriene-3,17-dione, on mouse embryo development in vitro. J Reprod Fertil. 66:1982;63-66.
23. Nawaz Z., Stancel G.M., Hyder S.M. The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription. Cancer Res. 59:1999;372-376.
24. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
25. Hyder SM, Kirkland JL, Loose-Mitchell DS, Mäkelä S, Stancel GM. Differential regulation of gene expression by estrogenic ligands: A potential basis for the toxicity of environmental estrogens. In: Naz RK, editor. Endocrine disruptors. Effects on male and female reproductive systems. Boca Raton, FL: CRC Press LLC. 1999. p. 165-86.
26. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
27. Berry M., Metzger D., Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promotor-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:1990;2811-2818.
28. Spearow J.L., Doemeny P., Sera R., Leffler R., Barkley M. Genetic variation in susceptibility to endocrine disruption by estrogen in mice. Science. 285:1999;1259-1261.
29. Bavister B.D., Andrews J.C. A rapid sperm motility bioassay procedure for quality-control testing of water and culture media. J In Vitro Fert Embryo Transf. 5:1988;67-75.
30. Nagel S.C., vom Saal F.S., Thayer K.A., Dhar M.G., Boechler M., Welshons W.V. Relative binding affinity serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect. 105:1997;70-76.
31. Hyder S.M., Stancel G.M., Loose-Mitchell D.S. Steroid hormone-induced expression of oncogene encoded nuclear proteins. Crit Rev Eukaryot Gene Exp. 4:1994;55-116.
32. Stancel G.M., Baker V.V., Hyder S.M., Kirkland J.L., Loose-Mitchell D.S. Oncogenes and uterine function. Oxford Rev Reprod Biol. 15:1993;1-42.
33. Rappolee D.A. Growth factors in mammalian pre- and postimplantation embryos. Dickson R.B., Salomon D.S. Hormones and growth factors in development and neoplasia. 1998;93-114 Wiley-Liss Inc, New York.